Chiang, Chien-Wei

Reducing acetylated tau is neuroprotective in brain injury

Shin, M.-K., Vázquez-Rosa, E., Koh, Y., Dhar, M., Chaubey, K., Cintrón-Pérez, C. J., Barker, S., Miller, E., Franke, K., Noterman, M. F., et al. (2021) · Cell

Alzheimer's disease research and treatmentsTraumatic Brain Injury Research

Cited by 226

Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer’s disease

Fang, J., Zhang, P., Zhou, Y., Chiang, C.-W., Tan, J., Hou, Y., Stauffer, S., Li, L., Pieper, A. A., Cummings, J., et al. (2021) · Nature Aging

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 206

Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease

Fang, J., Zhang, P., Wang, Q., Chiang, C.-W., Zhou, Y., Hou, Y., Xu, J., Chen, R., Zhang, B., Lewis, S. J., et al. (2022) · Alzheimer's Research & Therapy

Alzheimer's disease research and treatmentsComputational Drug Discovery Methods

Cited by 140

Comparative assessment of manual chart review and ICD claims data in evaluating immunotherapy-related adverse events

Nashed, A., Zhang, S., Chiang, C.-W., Zitu, M., Otterson, G. A., Presley, C. J., Kendra, K., Patel, S. H., Johns, A., Li, M., et al. (2021) · Cancer Immunology, Immunotherapy

Cancer Immunotherapy and BiomarkersMedical Coding and Health Information

Cited by 22